Kamila Wojas-Krawczyk Selected Research

Kamila Wojas-Krawczyk Research Topics

Disease

28	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 01/2008
25	Neoplasms (Cancer) 07/2023 - 01/2008
10	Lung Neoplasms (Lung Cancer) 02/2022 - 01/2008
5	Neoplasm Metastasis (Metastasis) 11/2018 - 01/2014
5	Adenocarcinoma 01/2018 - 02/2012
3	Adenocarcinoma of Lung 01/2020 - 02/2012
3	Weight Loss (Weight Reduction) 07/2017 - 01/2011
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2017
2	Asthma (Bronchial Asthma) 01/2017 - 01/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 03/2012
2	Anemia 12/2014 - 01/2011
1	Microsatellite Instability 08/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Infections 01/2021
1	Stomach Neoplasms (Stomach Cancer) 11/2020
1	Autoimmune Diseases (Autoimmune Disease) 08/2020
1	Second Primary Neoplasms (Neoplasms, Second) 08/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Necrosis 01/2020
1	Disease Progression 07/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 07/2015
1	Tobacco Use Disorder (Nicotine Dependence) 03/2012
1	Takayasu Arteritis (Arteritis, Takayasu's) 02/2012
1	Hypersensitivity (Allergy) 02/2012
1	Chronic Hepatitis B 02/2012
1	Exanthema (Rash) 01/2011

Drug/Important Bio-Agent (IBA)

6	Monoclonal AntibodiesIBA 10/2022 - 01/2009
5	Immune Checkpoint InhibitorsIBA 10/2022 - 09/2017
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2014
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2011
4	NivolumabIBA 01/2022 - 01/2020
4	ParaffinIBA 11/2020 - 01/2014
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2017 - 01/2011
3	B7-H1 AntigenIBA 10/2022 - 01/2019
3	pembrolizumabIBA 03/2022 - 04/2019
3	AntibodiesIBA 03/2022 - 01/2020
3	AntigensIBA 08/2021 - 01/2008
3	Formaldehyde (Formol)FDA Link 11/2020 - 01/2014
3	Anaplastic Lymphoma KinaseIBA 08/2018 - 07/2014
3	PlatinumIBA 07/2017 - 04/2012
2	Proteins (Proteins, Gene)FDA Link 10/2022 - 11/2020
2	LigandsIBA 08/2020 - 01/2020
2	atezolizumabIBA 01/2020 - 04/2019
2	Docetaxel (Taxotere)FDA Link 07/2017 - 01/2012
1	SurvivinIBA 10/2022
1	ElementsIBA 02/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	durvalumabIBA 01/2020
1	Mitogen-Activated Protein Kinase 3IBA 01/2020
1	carlina oxideIBA 01/2020
1	Antiparasitic Agents (Antiparasitics)IBA 01/2020
1	avelumabIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	IpilimumabIBA 04/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 07/2017
1	Subfamily B ATP Binding Cassette TransporterIBA 07/2017
1	Gefitinib (Iressa)FDA Link 06/2017
1	AfatinibIBA 06/2017
1	Codon (Codons)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	arginylarginine (Arg-Arg)IBA 01/2017
1	CaspasesIBA 01/2017
1	NucleotidesIBA 12/2014
1	Gemcitabine FDA Link 11/2013
1	Chromogranin AIBA 01/2013
1	SynaptophysinIBA 01/2013
1	CrizotinibIBA 01/2013
1	CotinineIBA 03/2012
1	Peptides (Polypeptides)IBA 02/2012
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2012
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2009
1	LipopolysaccharidesIBA 01/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2008
1	HLA-DR Antigens (HLA-DR)IBA 01/2008
1	VaccinesIBA 01/2008

Therapy/Procedure

21	Therapeutics 07/2023 - 01/2012
14	Immunotherapy 07/2023 - 02/2012
9	Drug Therapy (Chemotherapy) 01/2019 - 01/2011
2	Radiotherapy 11/2018 - 07/2014
1	Traditional Medicine (Folk Remedies) 01/2017